Defining menopausal status in epidemiologic studies: A comparison of multiple approaches and their effects on breast cancer rates.
about
Predicting invasive breast cancer versus DCIS in different age groupsReported mammographic density: film-screen versus digital acquisitionInfluence of reproductive history and exogenous hormone use on prevalence and frequency of circulating t(14;18)-positive cells in a population-based cross-sectional study.Follow-up and clinical significance of unsatisfactory liquid-based Papanicolaou tests.Anti-Müllerian hormone concentrations in premenopausal women and breast cancer riskEffects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 womenUse of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control studyEarly menopause predicts future coronary heart disease and stroke: the Multi-Ethnic Study of Atherosclerosis.Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.Endocrine therapy initiation from 2001 to 2008 varies by age at breast cancer diagnosis and tumor size.Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants, Prolactin and Breast Cancer.Characterizing inflammatory breast cancer among Arab Americans in the California, Detroit and New Jersey Surveillance, Epidemiology and End Results (SEER) registries (1988-2008).Breast cancer recurrence in relation to antidepressant use.Effects of transitioning from conventional methods to liquid-based methods on unsatisfactory Papanicolaou tests: results from a multicenter US study.Investigation of mammographic breast density as a risk factor for ovarian cancer.Factors associated with long-term adherence to annual surveillance mammography among breast cancer survivors.Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer.Evidence for Detection Bias by Medication Use in a Cohort Study of Breast Cancer Survivors.The Role of Biomarkers of Oxidative Stress in Breast Cancer Risk and Prognosis: A Systematic Review of the Epidemiologic Literature.Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis.Evaluation of multiple primary and combination screening strategies in postmenopausal women for detection of cervical cancer in China.Distress screening remains important during follow-up after primary breast cancer treatment.Effect of age at menopause on disease presentation in early rheumatoid arthritis: results from the Canadian Early Arthritis Cohort.Impact of Time Since Last Childbirth on Survival of Women with Premenopausal and Postmenopausal Breast Cancers.Obesity and survival in the neoadjuvant breast cancer setting: role of tumor subtype in an ethnically diverse population.Advanced glycation end-products (AGEs) and associations with cardio-metabolic, lifestyle, and dietary factors in a general population: the NQplus study.Bone metabolism dynamics in the early post-transplant period following kidney and liver transplantation.Serum adiponectin levels are associated with worse cognitive function in postmenopausal women.Risk of Breast Cancer With Long-Term Use of Calcium Channel Blockers or Angiotensin-Converting Enzyme Inhibitors Among Older Women.
P2860
Q21261250-759FDE21-E5A3-431C-ACD4-5477130D87D7Q30414634-78AE26E2-30C4-48E2-B7C0-12ADCBB08215Q35092570-634B83C3-B311-4D9C-9EB0-0F3ED611A910Q35168212-DE8D84B4-4276-4AA3-BC59-9077F36A3C5CQ35675000-E27025C8-758E-439D-9174-02E23E30C40CQ35921297-C417E041-FC8B-4D39-84B1-B887EE25B34FQ36153070-7BB0227A-4476-41F7-95D8-72E36D038239Q36237441-D436E415-004B-431E-BB04-451DEC806BF5Q36277707-97071085-4C21-41D7-B387-380EC97603C4Q36278395-A8711AD6-41D4-4AA5-8948-0D9B5CFCA08BQ36445716-C0D3D9CF-BF0F-49F6-B0B2-28A53833244FQ36598732-2FB57D5B-2C98-4D3F-AE5A-93F41470A3D4Q37020150-6A50CE65-6FAC-4A1D-8CF1-FDB70F622AC4Q37238881-DB844DB2-176D-4981-9EB0-3975182C401FQ37532651-FEB683AF-B05F-4F85-B873-6F6977F68087Q37604566-C3D9DBC6-8736-470D-8D39-B87136D6F53EQ37705334-7CB19A70-6DFE-417A-8F8D-5A921DDAA4E4Q38879569-6E23F286-2542-4544-8675-6DA4F22C4F5DQ39115159-91BE7DC1-43A3-4517-A78D-F4E57873A65AQ40062767-BD4140A2-1A18-46EA-802E-864A32D521D6Q40476346-8C8AAF13-D337-4ADE-831E-9EDB63D6D64FQ44299294-C5A10AAE-AE12-4E82-B9B3-89544B7E2544Q44844209-571AC39F-FF0D-46F3-A66E-A3B26E39F072Q47336398-8971CB33-2815-4B80-B669-BA67064A2431Q47921924-029438CF-63C6-47A9-86F7-8508D4173A44Q48178877-D50E3C5F-97FC-4F7B-9D1D-B860C42DDBF5Q48235237-BB8F3ACF-7837-4292-831E-FBD67048F59CQ48364606-38B92472-AD01-4E68-9941-18E1C882373DQ50899870-6A2453E5-5A30-4E63-BA1E-65147E9D8A1A
P2860
Defining menopausal status in epidemiologic studies: A comparison of multiple approaches and their effects on breast cancer rates.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Defining menopausal status in ...... ffects on breast cancer rates.
@ast
Defining menopausal status in ...... ffects on breast cancer rates.
@en
Defining menopausal status in ...... ffects on breast cancer rates.
@nl
type
label
Defining menopausal status in ...... ffects on breast cancer rates.
@ast
Defining menopausal status in ...... ffects on breast cancer rates.
@en
Defining menopausal status in ...... ffects on breast cancer rates.
@nl
prefLabel
Defining menopausal status in ...... ffects on breast cancer rates.
@ast
Defining menopausal status in ...... ffects on breast cancer rates.
@en
Defining menopausal status in ...... ffects on breast cancer rates.
@nl
P2093
P2860
P1433
P1476
Defining menopausal status in ...... ffects on breast cancer rates.
@en
P2093
Amanda I Phipps
Diana L Miglioretti
Diana S M Buist
Erin J A Bowles
Karla Kerlikowske
Laura Ichikawa
Patricia A Carney
P2860
P356
10.1016/J.MATURITAS.2010.04.015
P577
2010-05-21T00:00:00Z